Literature DB >> 11943256

Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study.

Nubia Muñoz1, Silvia Franceschi, Cristina Bosetti, Victor Moreno, Rolando Herrero, Jennifer S Smith, Keerti V Shah, Chris J L M Meijer, F Xavier Bosch.   

Abstract

BACKGROUND: High parity has long been suspected of being associated with an increased risk of cervical cancer, but previous analyses of this association have not taken the strong effect of human papillomavirus (HPV) into account. To assess the role of reproductive factors in the progression from HPV infection to cancer, we did a pooled analysis including only HPV-positive women.
METHODS: We pooled data from eight case-control studies on invasive cervical carcinoma (ICC) and two on in-situ carcinoma (ISC) from four continents. 1465 patients with squamous-cell ICCs, 211 with ISCs, 124 with adenocarcinomas or adenosquamous ICCs, and 255 control women, all positive for HPV DNA by PCR-based assays, were analysed. We calculated pooled odds ratios by means of unconditional multiple logistic regression models, and adjusted them for sexual and non-sexual confounding factors. The 95% CI were estimated by treating the odds ratio as floating absolute risk.
FINDINGS: We found a direct association between the number of full-term pregnancies and squamous-cell cancer risk: the odds ratio for seven full-term pregnancies or more was 3.8 (95% CI 2.7-5.5) compared with nulliparous women, and 2.3 (1.6-3.2) compared with women who had one or two full-term pregnancies. There was no significant association between risk of adenocarcinoma or adenosquamous carcinoma and number of full-term pregnancies.
INTERPRETATION: High parity increases the risk of squamous-cell carcinoma of the cervix among HPV-positive women. A general decline in parity might therefore partly explain the reduction in cervical cancer recently seen in most countries.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11943256     DOI: 10.1016/S0140-6736(02)08151-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  111 in total

1.  Association Between Risky Sexual Behavior and Cervical Cancer Screening Among Women in Kenya: A Population-Based Study.

Authors:  Zelalem T Haile; Caroline Kingori; Bhakti Chavan; John Francescon; Asli K Teweldeberhan
Journal:  J Community Health       Date:  2018-04

2.  Prevalence of human papillomavirus genotypes and associated cervical squamous intraepithelial lesions in HIV-infected women in Botswana.

Authors:  Iain J Macleod; Belinda O'Donnell; Sikhulile Moyo; Shahin Lockman; Roger L Shapiro; Mukendi Kayembe; Erik van Widenfelt; Joseph Makhema; M Essex; Carolyn Wester
Journal:  J Med Virol       Date:  2011-10       Impact factor: 2.327

3.  Risk factors for cervical cancer in criminal justice settings.

Authors:  Ingrid A Binswanger; Shane Mueller; C Brendan Clark; Karen L Cropsey
Journal:  J Womens Health (Larchmt)       Date:  2011-10-17       Impact factor: 2.681

4.  Bead-based multiplex genotyping of human papillomaviruses.

Authors:  Markus Schmitt; I G Bravo; Peter J F Snijders; Lutz Gissmann; Michael Pawlita; Tim Waterboer
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

5.  Cervical cancer and CYP2E1 polymorphisms: implications for molecular epidemiology.

Authors:  Paula M Ferreira; Raquel Catarino; Deolinda Pereira; Ana Matos; Daniela Pinto; Ana Coelho; Carlos Lopes; Rui Medeiros
Journal:  Eur J Clin Pharmacol       Date:  2005-12-22       Impact factor: 2.953

6.  Physical after effects and clients satisfaction following colposcopy and cervical biopsy in a Nigerian population.

Authors:  C A Okonkwo; M C Ezeanochie; B N Olagbuji
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

7.  Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists.

Authors:  Sang-Hyuk Chung; Paul F Lambert
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

8.  Role of estrogen receptor alpha in human cervical cancer-associated fibroblasts: a transcriptomic study.

Authors:  Mahesh M Kumar; Sravanthi Davuluri; Sridhar Poojar; Geetashree Mukherjee; Akhilesh Kumar Bajpai; Uttam Dungarmal Bafna; Uma K Devi; Pramod P R Kallur; Acharya K Kshitish; R S Jayshree
Journal:  Tumour Biol       Date:  2015-10-24

9.  Requirement for stromal estrogen receptor alpha in cervical neoplasia.

Authors:  Sang-Hyuk Chung; Myeong Kyun Shin; Kenneth S Korach; Paul F Lambert
Journal:  Horm Cancer       Date:  2012-10-13       Impact factor: 3.869

Review 10.  The biological properties of E6 and E7 oncoproteins from human papillomaviruses.

Authors:  Raffaella Ghittoni; Rosita Accardi; Uzma Hasan; Tarik Gheit; Bakary Sylla; Massimo Tommasino
Journal:  Virus Genes       Date:  2009-10-17       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.